FindTrial
Sign In

Comparison of the effect of transversus abdominis plane block or conventional analgesia on pain scores, patient satisfaction and incidence of chronic pelvic pain after total abdominal hysterectomy. - TAP Block For Total Abdominal Hysterectomy

Comparison of the effect of transversus abdominis plane block or conventional analgesia on pain scores, patient satisfaction and incidence of chronic pelvic pain after total abdominal hysterectomy. - TAP Block For Total Abdominal Hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-003168-20-GB
Enrollment
Unknown
Registered
2008-06-27
Start date
2008-08-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transversus abdominis plane block for postoperative pain relief in patients undergoing total abdominal hysterectomy.

Interventions

Trade Name: CHIROCAINE 0.5% Product Name: LEVOBUPIVACAINE Pharmaceutical Form: Solution for injection Trade Name: MORPHINE SULPHATE Product Name: MORPHINE SULPHATE Pharmaceutical Form: Solution for i

Sponsors

BELFAST HEALTH & SOCIAL CARE TRUST - BELFAST CITY HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for subjects i) ASA class I-III ii) Patients able to give written informed consent iii) Patients requiring total abdominal hysterectomy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Exclusion criteria i) Patients requiring total abdominal hysterectomy secondary to neoplasia ii) History of allergy to any of the medications used in the study iii) Preoperative use of opiates iv) Patients unable to use patient controlled analgesia system

Design outcomes

Primary

MeasureTime frame
Main Objective: The reduction in visual analogue scores (VAS) in the postoperative period for patients undergoing total abdominal hysterectomy.;Primary end point(s): Use of transversus abdominis plane blockade to reduce visual analogue scores for patients undergoing total abdominal hysterectomy as compared to a standard, opiate based postoperative analgesic technique.;Secondary Objective: 1. Reduction in usage of morphine sulphate in the postoperative period 2 Incidence of nausea and/or vomiting within the first 48 hours after surgery 3. Measurement of oxygen saturations without supplemental oxygen in both groups in the postoperative period 4. Incidence of complications associated with the analgesia techniques in both groups 5. Patient satisfaction with analgesia technique 6. Incidence of chronic pelvic pain at 3 months—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026